GBA1 and Parkinson disease: Accordingly, no accumulation of β-GC substrates was detected in GBA+/− mouse models or the brains of PD patients with heterozygous GBA1 mutations (Sardi et al., 2011; Farfel-Becker et al., 2014; Gegg and Schapira, 2016).